Privigen recall in Canada: adverse reactions
In plain language
This recall involves Privigen, an intravenous immunoglobulin product, sold in Canada. It's being recalled due to a series of adverse reactions. Consult your healthcare provider if you have this product.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use or for any health concerns.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Privigen
Lot: P100543004
Why this matters
Adverse reaction
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: P100543004
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Adverse reaction
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use or for any health concerns. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Adverse reaction
When was this product recalled?
This product was recalled on December 21, 2023.
Is the Privigen brand affected by this recall?
Yes, Privigen products are affected by this recall. This recall involves Privigen, an intravenous immunoglobulin product, sold in Canada. It's being recalled due to a series of adverse reactions. Consult your healthcare provider if you have this product.